Literature DB >> 9129928

Increased levels of circulating endothelial leukocyte adhesion molecule-1 (ELAM-1) in children with reflux nephropathy.

H Kobayashi1, Y Wang, P Puri.   

Abstract

OBJECTIVES: The aim of this study was to determine circulating levels of ELAM-1 in sera collected from patients with vesicoureteral reflux, and to investigate the relationship between circulating concentrations of ELAM-1 and reflux nephropathy.
METHODS: The serum levels of ELAM-1 were measured in 117 patients aged between 3 months and 13 years, with grade III to grade V vesicoureteral reflux, and 22 controls, by ELISA technique. Renal scarring was demonstrated in 46 of the 117 children on radionuclide scans.
RESULTS: The mean serum ELAM-1 levels were 54.23 +/- 20.11 ng/ml in controls and 77.79 +/- 34.50 ng/ml in children with vesicoureteral reflux (p < 0.05). The mean serum ELAM-1 levels in children with vesicoureteral reflux and renal scarring (104.48 +/- 34.53 ng/ml) were significantly higher than in children with VUR without renal scarring (60.51 +/- 20.85 ng/ml; p < 0.001).
CONCLUSION: These findings suggest that circulating ELAM-1 levels reflect increased tissue damage in children with vesicoureteral reflux, probably as a result of progressive localised inflammatory responses occurring in these patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129928     DOI: 10.1159/000474480

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  3 in total

1.  Plasma and urinary soluble adhesion molecule expression is increased during first documented acute pyelonephritis.

Authors:  R A Gbadegesin; S A Cotton; B M Coupes; A Awan; P E C Brenchley; N J A Webb
Journal:  Arch Dis Child       Date:  2002-03       Impact factor: 3.791

2.  Serum soluble vascular cell adhesion molecule-1 (VCAM-1) concentrations in children with reflux nephropathy.

Authors:  Kazuhiro Kaneyama; Hiroyuki Kobayashi; Atsuyuki Yamataka; Geoffrey J Lane; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

3.  Radiation safety and future innovative diagnostic modalities.

Authors:  Christian Radmayr
Journal:  Adv Urol       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.